![Mark L. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark L. Smith
No open positions remaining
Profile
Mark L.
Smith worked as a Chief Financial Officer and Group Controller at various biopharmaceutical companies such as Nabi Biopharmaceuticals, Replidyne, and Genzyme Corp.
He also served as the CFO and Head-Investor Relations at Gevo, Inc. and as the CFO at Nantenergy, Inc. Prior to his career in biopharmaceuticals, he worked as an Accountant at PricewaterhouseCoopers LLP.
Smith received his undergraduate degree from the University of Canberra.
Former positions of Mark L. Smith
| Companies | Position | End |
|---|---|---|
| GEVO, INC. | Director of Finance/CFO | 2013-10-02 |
Replidyne, Inc.
 Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Director of Finance/CFO | 2009-02-26 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Director of Finance/CFO | 2006-03-05 |
Neuromedical Systems, Inc.
 Neuromedical Systems, Inc. Medical SpecialtiesHealth Technology Develops, makes and markets a supplemental test to aid laboratories in the detection of abnormal cells | Director of Finance/CFO | 1998-12-31 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Comptroller/Controller/Auditor | 1997-12-31 |
Training of Mark L. Smith
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Neuromedical Systems, Inc.
Neuromedical Systems, Inc. Medical SpecialtiesHealth Technology Develops, makes and markets a supplemental test to aid laboratories in the detection of abnormal cells | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
Gevo, Inc.
 Gevo, Inc. Chemicals: SpecialtyProcess Industries Engages in the development and commercialization of alternatives to petroleum-based products | Process Industries |
Nantenergy, Inc.
 Nantenergy, Inc. Electrical ProductsProducer Manufacturing Manufactures and distributes power storage products | Producer Manufacturing |
Genetrix, Inc.
 Genetrix, Inc. Miscellaneous Commercial ServicesCommercial Services Genetics testing research | Commercial Services |
University of Canberra
 University of Canberra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mark L. Smith
